Flexible surrogate marker evaluation from several randomized clinical trials with continuous endpoints, using R and SAS
From MaRDI portal
Publication:1020068
DOI10.1016/j.csda.2007.02.007zbMath1162.62437OpenAlexW2054968322MaRDI QIDQ1020068
Assam Pryseley, Geert Molenberghs, Ariel Alonso, Abel Tilahun
Publication date: 29 May 2009
Published in: Computational Statistics and Data Analysis (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.csda.2007.02.007
hierarchical modelmeta-analysisrandom-effects modelsurrogate endpointrelative effectadjusted associationproportion explained
Related Items
Center-within-trial versus trial-level evaluation of surrogate endpoints ⋮ Using earlier measures in a longitudinal sequence as a potential surrogate for a later one ⋮ An information-theoretic approach to surrogate-marker evaluation with failure time endpoints
Uses Software
Cites Work
- Choice of units of analysis and modeling strategies in multilevel hierarchical models
- The evaluation of surrogate endpoints.
- Simplified hierarchical linear models for the evaluation of surrogate endpoints
- The validation of surrogate endpoints in meta-analyses of randomized experiments
- On meta-analytic assessment of surrogate outcomes
- Criteria for the Validation of Surrogate Endpoints in Randomized Experiments